Karyopharm Therapeutics
KPTI
KPTI
89 hedge funds and large institutions have $610M invested in Karyopharm Therapeutics in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 41 increasing their positions, 18 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
4% less capital invested
Capital invested by funds: $636M → $610M (-$25.8M)
31% less call options, than puts
Call options by funds: $2.86M | Put options by funds: $4.16M
Holders
89
Holding in Top 10
1
Calls
$2.86M
Puts
$4.16M
Top Buyers
| 1 | +$21.2M | |
| 2 | +$11.6M | |
| 3 | +$7.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$6.72M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.31M |
Top Sellers
| 1 | -$8.23M | |
| 2 | -$6.12M | |
| 3 | -$4.59M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$3.84M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$3.7M |